CRISPR Therapeutics AG (CRSP) Financials

The income statement of CRISPR Therapeutics AG (CRSP) provides a comprehensive overview of the company's financial performance. It shows the revenue generated by the company, as well as the costs and expenses incurred. The income statement includes various key figures, such as gross profit, operating income, and net income. These figures reflect the profitability of the company and its ability to generate profits from its operations. Additionally, the income statement also provides information on earnings before interest and taxes (EBIT) and earnings before interest, taxes, depreciation, and amortization (EBITDA).

The balance sheet of CRISPR Therapeutics AG (CRSP) provides a snapshot of the company's financial position at a specific point in time. It shows the company's assets, liabilities, and stockholders' equity. The balance sheet is divided into two main sections: assets and liabilities. The assets section includes cash, cash equivalents, and other assets, while the liabilities section includes debt and other liabilities. The balance sheet provides valuable information about the company's liquidity, solvency, and the value of its investments. Furthermore, it also shows the company's net debt, which is calculated by subtracting cash and cash equivalents from total debt. The stockholders' equity represents the owners' interest in the company and is calculated by subtracting total liabilities from total assets.

The cash flow statement of CRISPR Therapeutics AG (CRSP) provides information about the company's cash inflows and outflows during a specific period. It includes three main sections: operating activities, investing activities, and financing activities. The operating activities section shows the cash generated or used in the company's core operations, such as revenue from sales and payments to suppliers. The investing activities section shows the cash used for acquisitions, investments in property and equipment, and other long-term assets. The financing activities section shows the cash generated or used from activities such as issuing or repurchasing stock, borrowing or repaying debt, and paying dividends. The cash flow statement is crucial in assessing the company's ability to generate cash and its overall financial health. Lastly, the statement provides information on free cash flow, which is calculated by subtracting capital expenditures from operating cash flow. Free cash flow represents the cash available to the company after investing in its core operations and maintaining its assets.